Kidney transplantation outcomes across GN subtypes in the United States

Journal of the American Society of Nephrology

Volumn 28, Issue 2, 2017, Pages 632-644

  O'Shaughnessy, Michelle M ^a   Liu, Sai ^a   Montez Rath, Maria E ^a   Lenihan, Colin R ^a   Lafayette, Richard A ^a   Winkelmayer, Wolfgang C ^b  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALEMTUZUMAB; AZATHIOPRINE; BASILIXIMAB; CYCLOSPORIN A; DACLIZUMAB; MYCOPHENOLIC ACID; RAPAMYCIN; STEROID; TACROLIMUS; THYMOCYTE ANTIBODY;

ACUTE GRAFT REJECTION; ADULT; AGED; ARTICLE; CAUSE OF DEATH; CHRONIC GRAFT REJECTION; COHORT ANALYSIS; CONTROLLED STUDY; DEATH; DELAYED GRAFT FUNCTION; DIABETIC NEPHROPATHY; DISEASE ASSOCIATION; END STAGE RENAL DISEASE; FEMALE; FOCAL GLOMERULOSCLEROSIS; GLOMERULONEPHRITIS; GRAFT FAILURE; GRAFT INFECTION; GRAFT RECIPIENT; GRAFT THROMBOSIS; HAZARD RATIO; HEMODIALYSIS; HUMAN; IMMUNOGLOBULIN A NEPHROPATHY; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY GRAFT REJECTION; KIDNEY POLYCYSTIC DISEASE; KIDNEY TRANSPLANTATION; LUPUS ERYTHEMATOSUS NEPHRITIS; MAJOR CLINICAL STUDY; MALE; MEMBRANOPROLIFERATIVE GLOMERULONEPHRITIS; MEMBRANOUS GLOMERULONEPHRITIS; MIDDLE AGED; MORTALITY RATE; MULTICENTER STUDY; OLIGURIA; PERITONEAL DIALYSIS; PRIORITY JOURNAL; PROPORTIONAL HAZARDS MODEL; RISK FACTOR; SURGICAL RISK; SURVIVAL RATE; THROMBOSIS; TREATMENT OUTCOME; UNITED STATES; VASCULITIS; CLASSIFICATION; COMPLICATION; KIDNEY FAILURE, CHRONIC; MORTALITY;

ADULT; AGED; FEMALE; GLOMERULONEPHRITIS; HUMANS; KIDNEY FAILURE, CHRONIC; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; SURVIVAL RATE; TREATMENT OUTCOME; UNITED STATES;

EID: 85017578028     PISSN: 10466673     EISSN: 15333450     Source Type: Journal    
DOI: 10.1681/ASN.2016020126     Document Type: Article

References (42)

1. Rabbat CG, Thorpe KE, Russell JD, Churchill DN: Comparison of mortality risk for dialysis patients and cadaveric first renal transplant recipients in Ontario, Canada. J Am Soc Nephrol 11: 917-922, 2000
2. Wolfe RA, Ashby VB, Milford EL, OjoAO, Ettenger RE, Agodoa LY, Held PJ, Port FK: Comparison of mortality in all patients on dialysis, patients on dialysis awaiting transplantation, and recipients of a first cadaveric transplant. N Engl J Med 341: 1725-1730, 1999
3. Cameron JI, Whiteside C, Katz J, Devins GM: Differences in quality of life across renal replacement therapies: A meta-analytic comparison. Am J Kidney Dis 35: 629-637, 2000
4. United States Renal Data System: 2014 USRDS annual data report: Epidemiology of Kidney Disease in the United States. National Institutes ofHealth, National Institute of Diabetes andDigestive and Kidney Diseases, Bethesda, MD, 2014
5. Meier-Kriesche HU, Schold JD, Srinivas TR, Kaplan B: Lack of improvement in renal allograft survival despite a marked decrease in acute rejection rates over the most recent era. Am J Transplant 4: 378-383, 2004
6. Arend SM, Mallat MJ, Westendorp RJ, van der Woude FJ, van Es LA: Patient survival after renal transplantation; more than 25 years followup. Nephrol Dial Transplant 12: 1672-1679, 1997
7. Chailimpamontree W, Dmitrienko S, Li G, Balshaw R, Magil A, Shapiro RJ, Landsberg D, Gill J, Keown PA; Genome Canada Biomarkers in Transplantation Group: Probability, predictors, and prognosis of posttransplantation glomerulonephritis. J Am Soc Nephrol 20: 843-851, 2009
8. Briganti EM, Russ GR, McNeil JJ, Atkins RC, Chadban SJ: Risk of renal allograft loss from recurrent glomerulonephritis. N Engl J Med 347: 103-109, 2002
9. Hariharan S, Adams MB, Brennan DC, Davis CL, First MR, Johnson CP, Ouseph R, Peddi VR, Pelz CJ, Roza AM, Vincenti F, George V: Recurrent and de novo glomerular disease after renal transplantation: A report fromRenal Allograft Disease Registry (RADR). Transplantation 68: 635-641, 1999
10. Moroni G, Longhi S, Quaglini S, Rognoni C, Simonini P, Binda V, Montagnino G, Messa P: The impact of recurrence of primary glomerulonephritis on renal allograft outcome. Clin Transplant 28: 368-376, 2014
11. Mulay AV, van Walraven C, Knoll GA: Impact of immunosuppressive medication on the risk of renal allograft failure due to recurrent glomerulonephritis. Am J Transplant 9: 804-811, 2009
12. Toledo K, Pérez-Sáez MJ, Navarro MD, Ortega R, Redondo MD, Agüera ML, Rodríguez-Benot A, Aljama P: Impact of recurrent glomerulonephritis on renal graft survival. Transplant Proc 43: 2182-2186, 2011
13. Pippias M, Stel VS, Aresté-Fosalba N, Couchoud C, Fernandez-Fresnedo G, Finne P, Heaf JG, Hoitsma A, De Meester J, Pálsson R, Ravani P, Segelmark M, Traynor JP, Reisæter AV, Caskey FJ, Jager KJ: Long-term Kidney Transplant Outcomes in Primary Glomerulonephritis: Analysis From the ERA-EDTA Registry [published online ahead of print November 19, 2015]. Transplantation doi:10.1097/TP.0000000000000962
14. Chelamcharla M, Javaid B, Baird BC, Goldfarb-Rumyantzev AS: The outcome of renal transplantation among systemic lupus erythematosus patients. Nephrol Dial Transplant 22: 3623-3630, 2007
15. Ibrahim H, Rogers T, Casingal V, Sturdevant M, Tan M, Humar A, Gillingham K, Matas A: Graft loss from recurrent glomerulonephritis is not increased with a rapid steroid discontinuation protocol. Transplantation 81: 214-219, 2006
16. Kukla A, Chen E, Spong R, WeberM, El-Shahawi Y, Gillingham K, Matas AJ, Ibrahim HN: Recurrent glomerulonephritis under rapid discontinuation of steroids. Transplantation 91: 1386-1391, 2011
17. Oniscu GC, Brown H, Forsythe JL: Impact of cadaveric renal transplantation on survival in patients listed for transplantation. J Am Soc Nephrol 16: 1859-1865, 2005
18. Bunnapradist S, Chung P, Peng A, Hong A, Chung P, Lee B, Fukami S, Takemoto SK, Singh AK: Outcomes of renal transplantation for recipients with lupus nephritis: Analysis of the Organ Procurement and Transplantation Network database. Transplantation 82: 612-618, 2006
19. Kadiyala A, Mathew AT, Sachdeva M, Sison CP, Shah HH, Fishbane S, Jhaveri KD: Outcomes following Kidney transplantation in IgA nephropathy: A UNOS/OPTN analysis. Clin Transplant 29: 911-919, 2015
20. MoroniG, Gallelli B, Quaglini S, BanfiG, Montagnino G, Messa P. Longterm outcome of renal transplantation in adults with focal segmental glomerulosclerosis. Transplant Int 23, 208-216, 2010
21. Moroni G, Gallelli B, Quaglini S, Leoni A, Banfi G, Passerini P, MontagninoG, Messa P: Long-termoutcome of renal transplantation in patients with idiopathic membranous glomerulonephritis (MN). Nephrol Dial Transplant 25: 3408-3415, 2010
22. Shen J, Gill J, Shangguan M, Sampaio MS, Bunnapradist S: Outcomes of renal transplantation in recipients with Wegener's granulomatosis. Clin Transplant 25: 380-387, 2011
23. WardMM:Outcomes of renal transplantationamong patientswith endstage renal disease caused by lupus nephritis. Kidney Int 57: 2136-2143, 2000
24. Choy BY, Chan TM, Lo SK, Lo WK, Lai KN: Renal transplantation in patients with primary immunoglobulin A nephropathy. Nephrol Dial Transplant 18: 2399-2404, 2003
25. Hruskova Z, Stel VS, JayneD, Aasarød K, DeMeester J, Ekstrand A, Eller K, Heaf JG, Hoitsma A, Martos Jimenéz C, Ravani P, Wanner C, Tesar V, Jager KJ: Characteristics and Outcomes of Granulomatosis With Polyangiitis (Wegener) and Microscopic Polyangiitis Requiring Renal Replacement Therapy: Results Fromthe European Renal Association-European Dialysis and Transplant Association Registry. Am J Kidney Dis 66: 613-620, 2015
26. Moroni G, Casati C, Quaglini S, Gallelli B, Banfi G, Montagnino G, Messa P: Membranoproliferative glomerulonephritis type I in renal transplantation patients: A single-center study of a cohort of 68 renal transplants followed up for 11 years. Transplantation 91: 1233-1239, 2011
27. Tang W, Bose B, McDonald SP, Hawley CM, Badve SV, Boudville N, Brown FG, Clayton PA, Campbell SB, Peh CA, Johnson DW: The outcomes of patients with ESRD and ANCA-associated vasculitis in Australia and New Zealand. Clin J Am Soc Nephrol 8: 773-780, 2013
28. Little MA, Hassan B, Jacques S, Game D, Salisbury E, Courtney AE, Brown C, Salama AD, Harper L: Renal transplantation in systemic vasculitis: when is it safe?. Nephrol Dial Transplant 24: 3219-3225, 2009
29. Layton JB, Hogan SL, Jennette CE, Kenderes B, Krisher J, Jennette JC, McClellan WM: Discrepancy between Medical Evidence Form 2728 and renal biopsy for glomerular diseases. Clin J Am Soc Nephrol 5: 2046-2052, 2010
30. Krishnan M, Weinhandl ED, Jackson S, Gilbertson DT, Lacson E Jr: Comorbidity ascertainment from the ESRD Medical Evidence Report and Medicare claims around dialysis initiation: A comparison using US Renal Data System data. AmJ Kidney Dis 66: 802-812, 2015
31. Sethi S, Haas M, Markowitz GS, D'Agati VD, Rennke HG, Jennette JC, Bajema IM, Alpers CE, Chang A, Cornell LD, Cosio FG, Fogo AB, Glassock RJ, Hariharan S, Kambham N, Lager DJ, Leung N, Mengel M, Nath KA, Roberts IS, Rovin BH, Seshan SV, Smith RJ, Walker PD, Winearls CG, Appel GB, Alexander MP, Cattran DC, Casado CA, Cook HT, De Vriese AS, Radhakrishnan J, Racusen LC, Ronco P, Fervenza FC: Mayo Clinic/Renal Pathology Society Consensus Report on Pathologic Classification, Diagnosis, and Reporting of GN. J Am SocNephrol 27: 1278-1287, 2015
32. Chertow GM, Brenner BM, Mackenzie HS, Milford EL: Non-immunologic predictors of chronic renal allograft failure: Data fromthe United Network of Organ Sharing. Kidney Int Suppl 52: S48-S51, 1995
33. Cole E, Naimark D, Aprile M, Wade J, Cattran D, Pei Y, Fenton S, RobinetteM, Zaltsman J, Bear R, CardellaC: An analysis of predictors of long-termcadaveric renal allograft survival. Clin Transplant 9: 282-288, 1995
34. Meier-Kriesche HU, Arndorfer JA, Kaplan B: The impact of body mass index on renal transplant outcomes: A significant independent risk factor for graft failure and patient death. Transplantation 73: 70-74, 2002
35. Wu C, Evans I, Joseph R, Shapiro R, Tan H, Basu A, Smetanka C, Khan A, McCauley J, Unruh M: Comorbid conditions in kidney transplantation: Association with graft and patient survival. J AmSoc Nephrol 16: 3437-3444, 2005
36. Arce CM, Lenihan CR, Montez-RathME, WinkelmayerWC: Comparison of longer-term outcomes after kidney transplantation between Hispanic and non-Hispanic whites in the United States. Am J Transplant 15: 499-507, 2015
37. Montez-Rath ME, Winkelmayer WC, Desai M: Addressing missing data in clinical studies of kidney diseases. Clin J Am Soc Nephrol 9: 1328-1335, 2014
38. Hinchliffe SR, Lambert PC: Flexible parametric modelling of causespecific hazards to estimate cumulative incidence functions. BMCMed Res Methodol 13: 13, 2013
39. Ruan PK, Gray RJ: Analyses of cumulative incidence functions via nonparametric multiple imputation. Stat Med 27: 5709-5724, 2008
40. Allignol A, Beyersmann J: Software for fitting nonstandard proportional subdistribution hazards models. Biostatistics 11: 674-675, 2010
41. Zou G: A modified poisson regression approach to prospective studies with binary data. Am J Epidemiol 159: 702-706, 2004
42. McNutt LA, Wu C, Xue X, Hafner JP: Estimating the relative risk in cohort studies and clinical trials of common outcomes. Am J Epidemiol 157: 940-943, 2003